ICD-O coding of CNS tumours 
ICD-O topographical coding of central nervous system tumours
The ICD-O topography codes for the main anatomical sites covered in this volume are as follows [[Fritz A, Percy C, Jack A, et al., editors. International classification of diseases for oncology (ICD-O). 3rd ed. 1st rev. Geneva (Switzerland): World Health Organization; 2013.]]:

 

C70 Meninges

     C70.0 Cerebral meninges

     C70.1 Spinal meninges

     C70.9 Meninges, NOS

 

C71 Brain

     C71.0 Cerebrum

     C71.1 Frontal lobe

     C71.2 Temporal lobe

     C71.3 Parietal lobe

     C71.4 Occipital lobe

     C71.5 Ventricle, NOS

     C71.6 Cerebellum, NOS

     C71.7 Brain stem

     C71.8 Overlapping lesion of brain

     C71.9 Brain, NOS

 

C72 Spinal cord, cranial nerves, and other parts of central nervous system

     C72.0 Spinal cord

     C72.1 Cauda equina

     C72.2 Olfactory nerve

     C72.3 Optic nerve

     C72.4 Acoustic nerve

     C72.5 Cranial nerve, NOS

     C72.8 Overlapping lesion of brain and central nervous system

     C72.9 Nervous system, NOS

 

C75 Other endocrine glands and related structures

     C75.1 Pituitary gland

     C75.2 Craniopharyngeal duct

     C75.3 Pineal gland

 

ICD-O morphological coding: Introduction
The ICD-O coding system uses a topography (T) code and a morphology (M) code together, but these are presented in separate lists for ease of use. Behaviour is coded /0 for benign tumours; /1 for unspecified, borderline, or uncertain behaviour; /2 for carcinoma in situ and grade III intraepithelial neoplasia; /3 for malignant tumours, primary site; and /6 for malignant tumours, metastatic site. Behaviour code /6 is not generally used by cancer registries. For various reasons, the ICD-O morphology terms may not always be identical to the entity names used in the WHO classification, but they should be sufficiently similar to avoid confusion. The designation “NOS” (“not otherwise specified”) is provided to make coding possible when subtypes exist but exact classification may not be possible in small biopsies or certain other scenarios. Therefore, it is usual to have “NOS” even when a more specific alternative term is listed in ICD-O.

 

 

ICD-O coding of central nervous system tumours
ICD-O-3.2    ICD-O label (subtypes are indicated in grey text, with the label indented);

                     Please note that the WHO classification of tumour types is more readily reflected in the table of contents

Gliomas, glioneuronal tumours, and neuronal tumours

Adult-type diffuse gliomas

                     Astrocytoma, IDH-mutant

9400/3                Astrocytoma, IDH-mutant, grade 2

9401/3                Astrocytoma, IDH-mutant, grade 3

9445/3                Astrocytoma, IDH-mutant, grade 4

                     Oligodendroglioma, IDH-mutant and 1p/19q-codeleted

9450/3                Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 2

9451/3                Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, grade 3

9440/3          Glioblastoma, IDH-wildtype

 

Paediatric-type diffuse low-grade gliomas

9421/1          Diffuse astrocytoma, MYB- or MYBL1-altered†

9431/1          Angiocentric glioma

9413/0          Polymorphous low-grade neuroepithelial tumour of the young†

9421/1          Diffuse low-grade glioma, MAPK pathway–altered†

 

Paediatric-type diffuse high-grade gliomas

9385/3          Diffuse midline glioma, H3 K27–altered†

9385/3          Diffuse hemispheric glioma, H3 G34–mutant†

9385/3          Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype†

9385/3          Infant-type hemispheric glioma†

 

Circumscribed astrocytic gliomas

9421/1          Pilocytic astrocytoma

9421/3*        High-grade astrocytoma with piloid features

9424/3          Pleomorphic xanthoastrocytoma

9384/1          Subependymal giant cell astrocytoma

9444/1          Chordoid glioma

9430/3          Astroblastoma, MN1-altered†

 

Glioneuronal and neuronal tumours

9505/1          Ganglioglioma

9492/0          Gangliocytoma

9412/1          Desmoplastic infantile ganglioglioma

9412/1          Desmoplastic infantile astrocytoma

9413/0          Dysembryoplastic neuroepithelial tumour

n/a                 Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (provisional entity)

9509/1          Papillary glioneuronal tumour

9509/1          Rosette-forming glioneuronal tumour

9509/1          Myxoid glioneuronal tumour†

9509/3*        Diffuse leptomeningeal glioneuronal tumour

9509/0*        Multinodular and vacuolating neuronal tumour

9493/0          Dysplastic cerebellar gangliocytoma (Lhermitte–Duclos disease)

9506/1          Central neurocytoma

9506/1          Extraventricular neurocytoma

9506/1          Cerebellar liponeurocytoma

 

Ependymal tumours

9391/3          Supratentorial ependymoma, NOS†

9396/3          Supratentorial ependymoma, ZFTA fusion–positive†

9396/3          Supratentorial ependymoma, YAP1 fusion–positive†

9391/3          Posterior fossa ependymoma, NOS†

9396/3          Posterior fossa group A (PFA) ependymoma†

9396/3          Posterior fossa group B (PFB) ependymoma†

9391/3          Spinal ependymoma, NOS†

9396/3          Spinal ependymoma, MYCN-amplified†

9394/1          Myxopapillary ependymoma

9383/1          Subependymoma

 

Choroid plexus tumours

9390/0          Choroid plexus papilloma

9390/1          Atypical choroid plexus papilloma

9390/3          Choroid plexus carcinoma

 

Embryonal tumours

Medulloblastomas, molecularly defined

9475/3          Medulloblastoma, WNT-activated

9471/3          Medulloblastoma, SHH-activated and TP53-wildtype

9476/3          Medulloblastoma, SHH-activated and TP53-mutant

9477/3          Medulloblastoma, non-WNT/non-SHH

 

Medulloblastomas, histologically defined

9470/3          Medulloblastoma, histologically defined

9471/3                Desmoplastic nodular medulloblastoma

9471/3                Medulloblastoma with extensive nodularity

9474/3                Large cell medulloblastoma

9474/3                Anaplastic medulloblastoma

 

Other CNS embryonal tumours

9508/3          Atypical teratoid/rhabdoid tumour

n/a                 Cribriform neuroepithelial tumour (provisional entity)

9478/3          Embryonal tumour with multilayered rosettes

9500/3          CNS neuroblastoma, FOXR2-activated†

9500/3          CNS tumour with BCOR internal tandem duplication†

9473/3          CNS embryonal tumour, NEC/NOS

 

Pineal tumours

9361/1          Pineocytoma

9362/3          Pineal parenchymal tumour of intermediate differentiation

9362/3          Pineoblastoma

9395/3          Papillary tumour of the pineal region

n/a                 Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant (provisional entity)

 

Cranial and paraspinal nerve tumours

9560/0          Schwannoma

9540/0          Neurofibroma

9550/0                Plexiform neurofibroma

9571/0          Perineurioma

9563/0          Hybrid nerve sheath tumour

9540/3          Malignant melanotic nerve sheath tumour

9540/3          Malignant peripheral nerve sheath tumour

8693/3          Cauda equina neuroendocrine tumour (previously paraganglioma)

 

Meningioma

9530/0          Meningioma

 

Mesenchymal, non-meningothelial tumours involving the CNS

Fibroblastic and myofibroblastic tumours

8815/1          Solitary fibrous tumour

 

Vascular tumours

9121/0          Cavernous haemangioma

9131/0          Capillary haemangioma

9123/0          Arteriovenous malformation

9161/1          Haemangioblastoma

 

Skeletal muscle tumours

8910/3          Embryonal rhabdomyosarcoma

8920/3          Alveolar rhabdomyosarcoma

8901/3          Rhabdomyosarcoma, pleomorphic-type

8912/3          Spindle cell rhabdomyosarcoma

 

Tumours of uncertain differentiation

n/a                 Intracranial mesenchymal tumour, FET::CREB fusion–positive (provisional entity)

9367/3          CIC-rearranged sarcoma

9480/3          Primary intracranial sarcoma, DICER1-mutant†

9364/3          Ewing sarcoma

 

Chondrogenic tumours

9240/3          Mesenchymal chondrosarcoma

9220/3          Chondrosarcoma

9243/3          Dedifferentiated chondrosarcoma

 

Notochordal tumours

9370/3          Chordoma

 

Melanocytic tumours

Diffuse meningeal melanocytic neoplasms

8728/0          Meningeal melanocytosis

8728/3          Meningeal melanomatosis

 

Circumscribed meningeal melanocytic neoplasms

8728/1          Meningeal melanocytoma

8720/3          Meningeal melanoma

 

Haematolymphoid tumours involving the CNS

CNS lymphomas

9680/3          Primary diffuse large B-cell lymphoma of the CNS

9766/1          Lymphomatoid granulomatosis

9766/1                Lymphomatoid granulomatosis, grade 1

9766/1                Lymphomatoid granulomatosis, grade 2

9766/3                Lymphomatoid granulomatosis, grade 3

9712/3          Intravascular large B-cell lymphoma

 

Miscellaneous rare lymphomas in the CNS

9699/3          MALT lymphoma of the dura

9671/3          Lymphoplasmacytic lymphoma

9690/3          Follicular lymphoma

9714/3          Anaplastic large cell lymphoma (ALK+/ALK−)

9702/3          T-cell lymphoma

9719/3          NK/T-cell lymphoma

 

Histiocytic tumours

9749/3          Erdheim–Chester disease

9749/3          Rosai–Dorfman disease†

9749/1          Juvenile xanthogranuloma†

9751/1          Langerhans cell histiocytosis

9755/3          Histiocytic sarcoma

 

Germ cell tumours

9080/0          Mature teratoma

9080/3          Immature teratoma

9084/3          Teratoma with somatic-type malignancy

9064/3          Germinoma

9070/3          Embryonal carcinoma

9071/3          Yolk sac tumour

9100/3          Choriocarcinoma

9085/3          Mixed germ cell tumour

 

Tumours of the sellar region

9351/1          Adamantinomatous craniopharyngioma

9352/1          Papillary craniopharyngioma

9432/1          Pituicytoma

9582/0          Granular cell tumour of the sellar region

8290/0          Spindle cell oncocytoma

8272/3          Pituitary adenoma / pituitary neuroendocrine tumour (PitNET)†

8273/3          Pituitary blastoma

 